Transcarent to acquire Accolade Inc. for $7.03 per share, combining AI-driven care solutions with personalized healthcare expertise. Deal closes Q2 2025.
Why Is Accolade Stock Trading Over 100% On Tuesday?
Where Today's News Shapes Tomorrow
January 13, 2025
Headlines
